Please find below an outline of the PSI Conference for 2004.
For more details, please contact Ilsa Connolly on
[log in to unmask] (phone 01625 267880 ext 208).
PSI Conference 2004
Monday 10th May
PLENARY SESSION
How much shyster do you want with your quack?
The people behind the numbers: view of 'subjects' about their experience of
participating in trials
PARALLEL SESSIONS
1A. Adaptive Designs
- Can Regulators Adapt?
- Response Adaptive Clinical Trials ? Do the Benefits Outweigh the
Costs of Implementation?
- Optimal Designs for Phase I Oncology Studies
1B. Economic Evidence from Clinical Trials
- What is it that NICE want? Revised Guidance
- Meeting decision makers' needs ? Integration of economics and
patient reported outcomes (PROs) into global drug
development programmes
- [Third title TBC]
1C. New Starters (for those with no more than three years experience)
- Theil's U-Statistic
- Challenges of developing a novel assessment for Vascular
Dysfunction
- A comparison of Adaptive Allocation Rules for Group Sequential
Binary Response Clinical Trials
PLENARY SESSION
Dataset Analysis
Analysis of Recurrent Events, in the realm of survival analysis.
Tuesday 11th May
Parallel Statistical Computing Day (See below for details)
Parallel Non-Clinical Day (See below for details)
PLENARY SESSION
Data Safety Monitoring Boards
- Findings from the Damocles project: roles and responsibilities of
data monitoring committees in clinical trials
- Issues in clinical trial data monitoring
PARALLEL SESSIONS
2A. Contributed Papers
- Missing Data Issues in a Study of Transmission of Herpes
- Comparison of Sample-Size Methodology for Equivalence Studies
with Binary Outcomes
2B. Contributed Papers
- Prediction of LOCF endpoint by simulation and extrapolation based
on PK/PD, disease progress and dropout models
- [Second title TBC]
3A. Recent Developments in Statistical Methodology
- Data Mining
- Simulation-Based Methods in Statistics
3B. Tutorial Case Studies
- Stratified Binary Data and Logistic Regression
- Survival Data and Cox Regression
4A. Recent Developments in Statistical Methodology
- Some Examples of Statistical Methods for Medical Imaging Data
- Microarrays ? Applications and Analysis
4B. Tutorial Case Studies
- Repeated Measures Mixed Model Approach
- Non-Parametric Analysis
Parallel Statistical Computing Day
CDISC v3.0 Submission Domain Standards: A Statistical Programmer's Dream
Come True or Worst Nightmare?
Data Transformation from Differing Sources and Standards
"From Obstacles to Challenges" ? Statistical Programming in a CRO
environment
"Computer Systems Validation in Clinical Research ? A Practical Guide" ?
Version 2 is here!
Design Principles of a Reporting System
DARE to be different
An Annotate Gallery
Using R to produce plots: an introduction
Parallel Non-Clinical Day
Calibration ? some statistical principles
Approached to the analysis of pre-clinical tumour growth data from
xenograft studies
Analysis of repeated measurements in the area of regulatory toxicity
First dose in man and the impact of the Clinical Trial Directive
Bayesian Framework for Measures of Remembering Capacity
Use of factorial designs in the development of a receptor-ligand binding
assay
Wednesday 12th May
PARALLEL SESSIONS
5A. Professional Skills
- Presenting Statistics? Quick Tips
- Project Management: Breakdown Structure and Risk Management
- Consulting ? Should I stay or should I go?
5B. Contributed Papers
- Design and analysis of trials assessing the rate of disease
progression
- Nonparametric estimates of treatment effects
PLENARY SESSION
Clinical Development Plans
- Clinical Development Plans: What do regulators and health service
policy makers want?
- Life outside the Confidence Intervals: Framework Principles of
the Clinical Development Plan
- The Contribution of Statisticians to Clinical Development Plans
|